{"id":1283839,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Severe Urinary Tract Infection - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-05","captureTimestamp":"2026-02-05T21:03:24.320000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54001.html","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Severe Urinary Tract Infection A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) SGLT2 inhibitor use was not associated with an increased risk of severe UTI compared to use of DPP-4 inhibitors…","rawSnapshotUrl":"/api/snapshots/raw/1283839","browseUrl":"https://replay.healtharchive.ca/job-8/20260205210324/https://cihr-irsc.gc.ca/e/54001.html#ha_snapshot=1283839","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}